Impact of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients

The recruitment status of this study is unknown because the information has not been verified recently.

Verified October 2009 by Temple University.
Recruitment status was Recruiting

Sponsor:

Collaborator:

Wyeth is now a wholly owned subsidiary of Pfizer

Information provided by:

Temple University

ClinicalTrials.gov Identifier:

NCT00999258

First received: October 20, 2009

Last updated: NA

Last verified: October 2009

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	June 2011
Estimated Primary Completion Date:	June 2011 (Final data collection date for primary outcome measure)